Physician profile
David J Foreman
NPI 1730158320
$5,453.75
in general payments reported to CMS, 2019-2025
30 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $347 · 2021: $317 · 2022: $672 · 2023: $1,077 · 2024: $1,126 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.17 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,891.06 | 2019-2025 | Inspire |
| Optinose US, INC. | $1,035.55 | 2019-2025 | |
| Axsome Therapeutics, INC. | $451.79 | 2023-2025 | Sunosi |
| Genzyme Corporation | $415.01 | 2021-2025 | |
| Hikma Pharmaceuticals USA | $303.75 | 2022-2025 | Ryaltris |
| Glaxosmithkline, LLC. | $205.27 | 2021-2025 | Nucala |
| Stryker Corporation | $144.14 | 2019-2023 | Xpress Ent Dilation System |
| Ethicon US, LLC | $113.36 | 2019-2025 | Dermabond |
| Regeneron Healthcare Solutions, INC. | $106.99 | 2019-2025 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $103.20 | 2019-2020 | |
| Lundbeck LLC | $87.01 | 2023-2024 | Vyepti |
| Amgen INC. | $72.96 | 2019-2025 | Tezspire |
| Abbvie INC. | $67.11 | 2021-2022 | |
| Lilly USA, LLC | $66.37 | 2025 | Zepbound |
| Itamar Medical INC | $51.09 | 2023-2024 | Watchpatone |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $37.25 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $32.24 | 2025 | Xhance |
| Integra Lifesciences Corporation | $31.45 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Intersect Ent, INC. | $29.37 | 2020 | |
| Novartis Pharmaceuticals Corporation | $29.05 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.17 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.85 | 2019 | |
| Allergan, INC. | $20.41 | 2020 | |
| Acclarent, INC | $20.12 | 2023 | Acclarent Aera |
| Medtronic USA, INC. | $19.06 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.97 | 2022 | |
| Alk-Abello, INC | $15.97 | 2020 | |
| Kaleo, INC. | $15.50 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.85 | 2024 | Voquezna |
| Ucb, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.